Company profile
PROCEPT BioRobotics Corporation
NASDAQ: PRCT · Healthcare · Medical - Devices
#246 of 1,418 Healthcare companies by revenue74th-percentile growth
EA Score
63CFH 64DQ 61GM 65SS 61
v0.1 · 65/100 weight · provisional
↑ filing timeliness, workforce scale · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$322.0M
Rev growth YoY (TTM)
+29.3%
Net income (FY)
-$95.6M
Employees
888
as of 2026-08-10
Market cap
$1.2B
as of 2026-08-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$308.1M$308.1M2025
Net income-$95.6M-$95.6M2025
Operating income-$103.9M-$103.9M2025
Total assets$508.1M$508.1M2025
Liabilities$142.2M$142.2M2025
Equity$365.9M$365.9M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is PROCEPT BioRobotics Corporation’s revenue?
PROCEPT BioRobotics Corporation booked $308.1M in FY2025 revenue, growing 37% year over year — faster than most Healthcare companies we track, at a -31.0% net margin.
Peers · Healthcare
Eagle Pharmaceuticals, Inc.——CorMedix Inc.75B+Health Catalyst, Inc.56CBillionToOne, Inc.53DHealthStream, Inc.82B+The Beauty Health Company57CNeighbors
Santa Clara →Key facts
CEOLarry L. Wood
SectorHealthcare
IndustryMedical - Devices
HeadquartersSan Jose, CA
ExchangeNASDAQ: PRCT
Employees888
IPO date2021-09-15
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.